Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Time to see the light.
Limb Apraxia in Multiple Sclerosis: Prevalence and Impact on Manual Dexterity and Activities of Daily Living.
Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients.
Cortical lesion load correlates with diffuse injury of multiple sclerosis normal appearing white matter.
Homophilic interaction of the L1 family of cell adhesion molecules.
Exploring the human tear fluid: discovery of new biomarkers in multiple sclerosis.
Long-term efficacy, tolerability and retention rate of azathioprine in 103 aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder patients: a multicentre retrospective observational study from the UK.
Effect of intramuscular interferon beta-1a on gray matter atrophy in relapsing-remitting multiple sclerosis: A retrospective analysis.
Switching to Gilenya® (fingolimod) from a standard interferon offers sustained freedom from disease activity for people with relapsing remitting multiple sclerosis
HLA-DRB1-DQB1 Haplotypes Confer Susceptibility and Resistance to Multiple Sclerosis in Sardinia.
Inhibition by riluzole of electrophysiological responses mediated by rat kainate and NMDA receptors expressed in Xenopus oocytes.
Toll-like receptors in central nervous system injury and disease: A focus on the spinal cord.
The potential for new therapeutic approaches: Global research collaboration examines multiple pathways of neuroprotection in Huntington disease
Quality of life in the care home: a qualitative study of the perspectives of residents with multiple sclerosis.
Association of NOD1 and NOD2 polymorphisms with Guillain-Barré syndrome in Northern Indian population.
Granzyme B-Induced Neurotoxicity Is Mediated via Activation of PAR-1 Receptor and Kv1.3 Channel.
Video game training enhances cognitive control in older adults.
Personalized Medicine in Neurodegenerative Diseases: How Far Away?
DMDs Are an Essential Issue But Are They the Only Issue in MS Treatment?
The olfactory vector hypothesis of neurodegenerative disease: is it viable?
Oral fingolimod (FTY720) for relapsing multiple sclerosis.
Amelioration of experimental autoimmune encephalomyelitis by anatabine.
No increase in cancer incidence detected after cyclophosphamide in a French cohort of patients with progressive multiple sclerosis.
Emerging roles of exosomes in neuron-glia communication.
Correction: Adherence to Interferon β-1b Treatment in Patients with Multiple Sclerosis in Spain.

Pages